> Peptides > BioTides™

BioTides™

Biotinylated peptides are widely used in a variety of biomedical screening systems requiring immobilization of at least one of the interaction partners onto streptavidin coated beads, membranes, glass slides or microtiter plates. By means of its proprietary SPOT™ synthesis technology, JPT Peptide Technologies provides access to large numbers of biotinylated peptides at unmatched prices and fastest delivery time.
Quote Request

Benefits

  • Thousands of unpurified biotinylated peptides for screening and peptide array production.
  • Unmatched turnaround times (10 000 peptides per week!).
  • Delivery in ready-to-use microtiter plates.
  • Lowest price in the industry due to patented technology
    (U$0.99 per amino acid residue).
  • Complete QC (LC-MS, MALDI etc.) and aliquotation service available.


Detection of BioTides™

Applications

  • Identification and optimization of kinase-, phosphatase-, acetyltransferase- and histone deacetylase-substrates via standard screening systems (AlphaScreen, FlashPlates, SPA-Beads, and many more).
  • Mapping of protein/protein interaction sites
    (ELISA-like assays, precipitation of interacting proteins).
  • Production of peptide microarrays.
  • Loading of columns for affinity chromatography.

Example: Human c-Jun derived BioTides and protein tyrosine kinase c-Abl

Used reagents and materials:

  • 384 well microtiter plate containing 160 different BioTides derived from human c-Jun protein
  • Abl-kinase (New England BioLabs, www.neb.com, item# P6050L)
  • Kinase buffer 50 mM Tris-HCl, 10 µM MgCl2 1 mM EGTA, 2 mM DTT, and 0.01% Brij 35 (pH 7.5, 25°C)
  • SAM-Biotin capture membrane (Promega, # V7861)
  • 384 pin replicator (Genetix, 384-pin QReps-PP, Product Code: X5050, printing volume approx: 0.2 µl)
Wells of a microtiter plate each containing 1 nanomole BioTide were incubated with 2 Units c-Abl in the presence of 400 µM ATP using 20 µl kinase buffer per well for 3h at 30°C. The resulting final BioTide concentration was 50 µM. Subsequent to incubation aliquots of assay solution were printed directly on SAM-Biotin capture membrane using a 384 pin replicator followed by washings (two times) with TBS-buffer (50 mM Tris-HCl, 137 mM NaCl, 2,7 mM KCl (pH 8, 25°C). The SAM-membrane was blocked for 1h with blocking reagent from Roche Diagnostics (dilution 1:10, # 1 096 176)

Position SEQ
A6 DDALNASFLPSES
A7 ALNASFLPSESGP
A8 NASFLPSESGPYG
A9 SFLPSESGPYGYS
A10 LPSESGPYGYSNP
A11 SESGPYGYSNPKI
A12 SGPYGYSNPKILK
B1 PYGYSNPKILKQS
B2 GYSNPKILKQSMT
B3 SNPKILKQSMTLN
B4 PKILKQSMTLNLA
...
G5 GSGSGGFSASLHS
G6 GSGGFSASLHSEP
G7 GGFSASLHSEPPV
G8 FSASLHSEPPVYA
G9 ASLHSEPPVYANL
G10 LHSEPPVYANLSN
G11 SEPPVYANLSNFN
G12 PPVYANLSNFNPG
H1 VYANLSNFNPGAL
H2 ANLSNFNPGALSS
H3 LSNFNPGALSSGG
H4 NFNPGALSSGGGA
...
O1-O4 ATP + Buffer
O5 QSRRS-pT-QGVTL*
O6 LRRRFS-pS-LHF*
O7 NDEN-pY-HPRESS*
O8 Kinase
O9 Buffer
O10 QSRRS-pT-QGVTL*
O11 LRRRFS-pS-LHF*
O12 NDEN-pY-HPRESS*
P1 Kinase + ATP
P2 Kinase + ATP
P3 Kinase + ATP
P4 Kinase + ATP
P5 QSRRS-pT-QGVTL*
P6 LRRRFS-pS-LHF*
P7 NDEN-pY-HPRESS*
P8 Kinase
P9 Buffer
P10 QSRRS-pT-QGVTL*
P11 LRRRFS-pS-LHF*
P12 NDEN-pY-HPRESS*
 

Figure 1: Fluorescence image of SAM-Biotin capture membrane subsequent to antibody treatment

SAM-Membrane was incubated with FITC-labelled monoclonal anti-phosphotyrosine antibody PT-66 (Sigma, Order# F3145) (dilution 1:1000 in TBS) for 150 min followed by washings (5 times) with TBS-buffer. Fluorescence image was generated using FLA 3000 reader (Fuji, excitation at 473 nm, fluorescence filter 520 nm).

 

Figure 2: Chemoluminescence image of SAM-Biotin capture membrane subsequent to antibody treatment

AM-Membrane prepared using a diluted (1:100) assay solution was incubated with POD-labelled monoclonal anti-phosphotyrosine antibody PT-66 (Sigma, www.sigmaaldrich.com, Order# A5964) (dilution 1:1000 in TBS) for 240 min followed by washings (5 times) with TBS-buffer. Chemoluminescence image was generated using LumiImager (Roche Diagnostics) and BM chemiluminescence blotting substrate (Roche Diagnostics, # 1500694)

pS/pT/pY positive controls; * pS=phospho-Ser; pT=phospho-Thr; pY=phospho-Tyr
negative controls
G8-H1 known phosphorylation-site: Barila D, Mangano R, Gonfloni S, Kretzschmar J, Moro M, Bohmann D, Superti-Furga G.; A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK; EMBO J. 2000 Jan 17;19(2):273-81;;
 
Please inquire about additional services not listed here